Fujifilm completes acquisition of Atara's cell therapy manufacturing site near Los Angeles

Josh Sullivan

In January, Atara Biotherapeutics inked a deal with Fujifilm Diosynth to exchange its California manufacturing site for $100 million upfront, and a long-term licensing deal …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Fujifilm completes acquisition of Atara's cell therapy manufacturing site near Los Angeles

Josh Sullivan

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Trump blog: Judge extends nationwide block on NIH payment cuts

RFK Jr. readies review of childhood vaccine schedule after pledging not to

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Fu­ji­film com­pletes ac­qui­si­tion of Atara's cell ther­a­py man­u­fac­tur­ing site near Los An­ge­les

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Fujifilm completes acquisition of Atara's cell therapy manufacturing site near Los Angeles